PDM-31 (HCM-CSHL-0080-C25) is a patient-derived pancreatic ductal adenocarcinoma organoid model developed through the Human Cancer Models Initiative (HCMI) and distributed by ATCC for research use. It was isolated from primary pancreatic tumor tissue and is intended for 3D cell culture, cancer research, basic research, and compound screening.
- Organoid morphology suitable for 3D cell culture.
- Derived from primary pancreatic adenocarcinoma tissue.
- Biosafety level BSL 1, suitable for standard laboratory handling.
- Applicable to cancer research, pharmacological screening, and basic research.
- Linked clinical and bioinformatics data available through HCMI resources.